Gold bars to be exempt from tariffs, White House clarifies
LONDON - Induction Healthcare Group PLC (Induction), a healthcare technology company, has agreed to a recommended cash acquisition by VitalHub UK Limited (Bidco), a subsidiary of VitalHub Corp. The acquisition, announced on April 10, 2025, is to be executed via a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006, as per the terms and conditions detailed in the scheme document published on April 17, 2025.
Today, Induction dispatched Rule 15 Letters to participants of the Induction Share Plan, informing them about the impact of the acquisition on their options and awards. The letter outlines the proposals being made to them, along with relevant dates and times. Participants can access this information on Induction’s website, with availability extending until the acquisition’s effective date.
The acquisition process, which is subject to the conditions set out in the scheme document, marks a significant transition for Induction as it joins forces with Bidco. The terms and conditions of the acquisition are fully detailed in the scheme document, which is available on the websites of both Induction and Bidco.
This development is a key event for shareholders and participants in the Induction Share Plan, who are advised to make their decisions based on the information provided in the scheme document. The letter sent to the Induction Share Plan participants is a crucial document that will guide them through the acquisition process.
The information in this article is based on a press release statement issued by Induction Healthcare Group PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.